litlas
Log inCreate account

Gary A. Rosenberg

Active 1977–2025

93
Papers
21,620
Citations
77
h-index
90
i10-index

Citations

Citations per year for Gary A. Rosenberg1978: 1 citations1981: 2 citations1982: 2 citations1983: 2 citations1984: 2 citations1985: 2 citations1986: 3 citations1987: 7 citations1988: 4 citations1989: 4 citations1990: 8 citations1991: 7 citations1992: 13 citations1993: 13 citations1994: 14 citations1995: 18 citations1996: 24 citations1997: 47 citations1998: 72 citations1999: 74 citations2000: 83 citations2001: 121 citations2002: 149 citations2003: 136 citations2004: 119 citations2005: 170 citations2006: 147 citations2007: 210 citations2008: 226 citations2009: 223 citations2010: 239 citations2011: 251 citations2012: 275 citations2013: 249 citations2014: 217 citations2015: 284 citations2016: 216 citations2017: 239 citations2018: 230 citations2019: 576 citations2020: 645 citations2021: 738 citations2022: 655 citations2023: 534 citations2024: 709 citations2025: 338 citations2026: 16 citations1979–1980: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,488 citing papers, 28.8% of this breakdownChina: 1,334 citing papers, 15.4% of this breakdownUnited Kingdom: 553 citing papers, 6.4% of this breakdownGermany: 405 citing papers, 4.7% of this breakdownCanada: 381 citing papers, 4.4% of this breakdownItaly: 278 citing papers, 3.2% of this breakdownJapan: 230 citing papers, 2.7% of this breakdownNetherlands: 222 citing papers, 2.6% of this breakdownSouth Korea: 215 citing papers, 2.5% of this breakdownAustralia: 203 citing papers, 2.3% of this breakdownFrance: 183 citing papers, 2.1% of this breakdownSpain: 168 citing papers, 1.9% of this breakdown
0%28.8%Other 23%

Institutions

Fields

  • Medicine43.9%
  • Neuroscience31.8%
  • Biochemistry, Genetics and Molecular Biology17.7%
  • Immunology and Microbiology2%
  • Engineering1.4%
  • Materials Science0.9%
  • Other2.3%

Topics

  • Neuroinflammation and Neurodegeneration Mechanisms7.7%
  • Neurological Disease Mechanisms and Treatments5.7%
  • Barrier Structure and Function Studies5.3%
  • Acute Ischemic Stroke Management4.5%
  • Protease and Inhibitor Mechanisms3.1%
  • Dementia and Cognitive Impairment Research2.8%
  • Other70.9%

Coauthors

All papers

Open in search
  1. Neuroinflammation: friend and foe for ischemic stroke

    Authors: Richard L. Jayaraj, Sheikh Azimullah, Rami Beiram, Fakhreya Y. Jalal, Gary A. Rosenberg - Journal of Neuroinflammation 2019 cited by 1,429

  2. Blood–Brain Barrier Breakdown in Acute and Chronic Cerebrovascular Disease

    Authors: Yi Yang, Gary A. Rosenberg - Stroke 2011 cited by 784

  3. National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards

    Authors: Vladimir Hachinski, Costantino Iadecola, Ron Petersen, Monique M.B. Breteler, David L. Nyenhuis, Sandra E. Black, William J. Powers, Charles DeCarli, José G. Merino, Raj N. Kalaria, Harry V. Vinters, David M. Holtzman, Gary A. Rosenberg, Anders Wallin, Martin Dichgans, John R. Marler, Gabrielle G. Leblanc - Stroke 2006 cited by 1,718

  4. Matrix Metalloproteinase-Mediated Disruption of Tight Junction Proteins in Cerebral Vessels is Reversed by Synthetic Matrix Metalloproteinase Inhibitor in Focal Ischemia in Rat

    Authors: Yi Yang, Eduardo Y. Estrada, Jeffrey F. Thompson, Wenlan Liu, Gary A. Rosenberg - Journal of Cerebral Blood Flow & Metabolism 2006 cited by 1,055

  5. Neurological Diseases in Relation to the Blood–Brain Barrier

    Authors: Gary A. Rosenberg - Journal of Cerebral Blood Flow & Metabolism 2012 cited by 450

  6. Microglial activation and blood–brain barrier permeability in cerebral small vessel disease

    Authors: Jessica Walsh, Dan Tozer, Hasan Sari, Young T. Hong, Anna M. Drazyk, Guy Williams, N. Jon Shah, John T. O’Brien, Franklin I. Aigbirhio, Gary A. Rosenberg, Tim D. Fryer, Hugh S. Markus - Brain 2021 cited by 173

  7. Placental growth factor as a sensitive biomarker for vascular cognitive impairment

    Authors: Jason D. Hinman, Fanny M. Elahi, Davis S. Chong, Hannah L. Radabaugh, Adam R. Ferguson, Pauline Maillard, Jeffrey F. Thompson, Gary A. Rosenberg, Abhay P. Sagare, Abhay Moghekar, Hanzhang Lu, Tiffany Lee, Donna M. Wilcock, Claudia L. Satizábal, Russell P. Tracy, Sudha Seshadri, Kristin Schwab, Karl G. Helmer, Herpreet Singh, Pia Kivisäkk, S Greenberg, Charlie S. DeCarli, Joel H. Kramer - Alzheimer s & Dementia 2023 cited by 63

  8. Altered static and dynamic functional network connectivity in Alzheimer's disease and subcortical ischemic vascular disease: shared and specific brain connectivity abnormalities

    Authors: Zening Fu, Arvind Caprihan, Jiayu Chen, Yuhui Du, John C. Adair, Jing Sui （Beijing Normal University）， my correct affiliation is beijing normal university, not Qingdao University of Science and Technology, please correct the current affiliation. Thank you, Gary A. Rosenberg, Vince D. Calhoun - Human Brain Mapping 2019 cited by 181

  9. Proteopathic tau primes and activates interleukin-1β via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway

    Authors: Shanya Jiang, Nicole Maphis, Jessica Binder, Devon Chisholm, Lea L. Weston, Walter Duran, Crina Peterson, Amber Zimmerman, Michael A. Mandell, Stephen D. Jett, Eileen H. Bigio, Changiz Geula, Nikolaos Mellios, Jason P. Weick, Gary A. Rosenberg, Eicke Latz, Michael T. Heneka, Kiran Bhaskar - Cell Reports 2021 cited by 88

  10. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols

    Authors: Donna M. Wilcock, Gregory A. Jicha, Deborah Blacker, Marilyn Albert, Lina M. D’Orazio, Fanny M. Elahi, Myriam Fornage, Jason D. Hinman, Janice E. Knoefel, Joel H. Kramer, Richard J. Kryscio, Melissa Lamar, Abhay Moghekar, Jillian Prestopnik, John M. Ringman, Gary A. Rosenberg, Abhay P. Sagare, Claudia L. Satizábal, Julie A. Schneider, Sudha Seshadri, Sandeepa Sur, Russell P. Tracy, Sevil Yaşar, Victoria J. Williams, Herpreet Singh, Lidiya Mazina, Karl G. Helmer, Roderick A. Corriveau, Kristin Schwab, Pia Kivisäkk, Steven M. Greenberg - Alzheimer s & Dementia 2021 cited by 95

  11. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

    Authors: Gary A. Rosenberg - The Lancet Neurology 2009 cited by 573

  12. Consensus statement for diagnosis of subcortical small vessel disease

    Authors: Gary A. Rosenberg, Anders Wallin, Joanna M. Wardlaw, Hugh S. Markus, Joan Montaner, Leslie Wolfson, Costantino Iadecola, Berislav V. Zloković, Anne Joutel, Martin Dichgans, Marco Duering, Reinhold Schmidt, Amos D. Korczyn, Lea T. Grinberg, Helena C. Chui, Vladimir Hachinski - Journal of Cerebral Blood Flow & Metabolism 2015 cited by 226

  13. Extracellular matrix inflammation in vascular cognitive impairment and dementia

    Authors: Gary A. Rosenberg - Clinical Science 2017 cited by 185

  14. Matrix metalloproteinases as therapeutic targets for stroke

    Authors: Yi Yang, Gary A. Rosenberg - Brain Research 2015 cited by 238

  15. MRI measurements of Blood-Brain Barrier function in dementia: A review of recent studies

    Authors: Rajikha Raja, Gary A. Rosenberg, Arvind Caprihan - Neuropharmacology 2017 cited by 176

  16. Blood–Brain Barrier Permeability Abnormalities in Vascular Cognitive Impairment

    Authors: Saeid Taheri, Charles Gasparovic, Branko N. Huisa, John C. Adair, Elaine S. Edmonds, Jillian Prestopnik, Mark Grossetete, N. Jon Shah, John E. Wills, Clifford Qualls, Gary A. Rosenberg - Stroke 2011 cited by 258

  17. Instrumental validation of free water, peak‐width of skeletonized mean diffusivity, and white matter hyperintensities: MarkVCID neuroimaging kits

    Authors: Pauline Maillard, Hanzhang Lu, Konstantinos Arfanakis, Brian T. Gold, Christopher E. Bauer, Valentinos Zachariou, Lara Stables, Danny J.J. Wang, Kay Jann, Sudha Seshadri, Marco Duering, Laura J. Hillmer, Gary A. Rosenberg, Haykel Snoussi, Farshid Sepehrband, Mohamad Habes, Baljeet Singh, Joel H. Kramer, Roderick A. Corriveau, Herpreet Singh, Kristin Schwab, Karl G. Helmer, Steven M. Greenberg, Arvind Caprihan, Charles DeCarli, Claudia L. Satizábal - Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2022 cited by 85

  18. Matrix metalloproteinases in neuroinflammation

    Authors: Gary A. Rosenberg - Glia 2002 cited by 857

  19. Blood-brain barrier disruption measured by albumin index correlates with inflammatory fluid biomarkers

    Authors: Laura J. Hillmer, Erik B. Erhardt, Arvind Caprihan, John C. Adair, Janice E. Knoefel, Jill Prestopnik, Jeffrey Thompson, Sasha Hobson, Gary A. Rosenberg - Journal of Cerebral Blood Flow & Metabolism 2022 cited by 54

  20. Matrix Metalloproteinases and TIMPs Are Associated With Blood-Brain Barrier Opening After Reperfusion in Rat Brain

    Authors: Gary A. Rosenberg, Eduardo Y. Estrada, John E. Dencoff - Stroke 1998 cited by 855

  21. Collagenase-induced intracerebral hemorrhage in rats.

    Authors: Gary A. Rosenberg, Sheila Mun-Bryce, Mary H. Wesley, Mario Kornfeld - Stroke 1990 cited by 608

  22. Strategies to advance translational research into brain barriers

    Authors: Edward A. Neuwelt, N. Joan Abbott, Lauren E. Abrey, William A. Banks, Brian W. Blakley, Thomas P. Davis, Britta Engelhardt, Paula Grammas, Maiken Nedergaard, John G. Nutt, William M. Pardridge, Gary A. Rosenberg, Quentin R. Smith, Lester R. Drewes - The Lancet Neurology 2008 cited by 469

  23. Matrix Metalloproteinases Are Associated With Increased Blood–Brain Barrier Opening in Vascular Cognitive Impairment

    Authors: Eduardo Candelario‐Jalil, Jeffrey Thompson, Saeid Taheri, Mark Grossetete, John C. Adair, Elaine S. Edmonds, Jillian Prestopnik, John E. Wills, Gary A. Rosenberg - Stroke 2011 cited by 168

  24. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia

    Authors: Eduardo Candelario‐Jalil, Yirong Yang, Gary A. Rosenberg - Neuroscience 2008 cited by 516